Health News Releases

  • Today April 8
April 21, 2020 16:36
European Commission approves nintedanib for the treatment of systemic sclerosis-associated interstitial lung disease (SSc-ILD)
Boehringer Ingelheim today announced that the European Commission has approved nintedanib for the treatment of systemic sclerosis-associated interstitial lung disease (SSc-ILD) in adults.[2] The appro
April 21, 2020 16:32
VFMCRP and Cara Therapeutics announce positive results from global KALM-2 pivotal phase-III trial of KORSUVA™ injection in haemodialysis patients with Pruritus
Regulatory News: Vifor Fresenius Medical Care Renal Pharma (VFMCRP) and Cara Therapeutics, Inc. (Nasdaq:CARA) today announced positive topline data from Cara’s KALM-2 pivotal phase-III trial of KOR
April 16, 2020 14:24
Ventilator Manufacturers Unite to Form Ventilator Training Alliance and Create App to Help Frontline Medical Workers During COVID-19 Pandemic
Several of the world’s ventilator manufacturers have formed a Ventilator Training Alliance (VTA) and partnered with Allego to create a mobile app that frontline medical providers can use to access a c
April 16, 2020 09:25
Samsung Bioepis Announces US Launch of ONTRUZANT® (trastuzumab-dttb) for Early and Metastatic HER2-overexpressing Breast Cancer and Metastatic Gastric Cancer
Samsung Bioepis Co., Ltd. announced today that ONTRUZANT® (trastuzumab-dttb), a biosimilar of the reference biologic medicine HERCEPTIN®[1] (trastuzumab) for the treatment of HER2-overexpressing breas
April 15, 2020 13:47
Biolytic Introduces the Dr. Oligo 768XLc DNA RNA Synthesizer - Synthesizing 768 Oligos Just Got Faster
Biolytic Lab Performance Inc. unveiled its novel oligo synthesizer, the Dr. Oligo 768XLc, the most commercially advanced platform for high throughput nucleic acid synthesis. Designed to be operated in
April 14, 2020 13:53
Covetrus Integrates Telemedicine Capabilities Across Its Global Technology Portfolio
Covetrus (NASDAQ: CVET), a global leader in animal-health technology and services, announced today that it is embedding secure video teleconferencing capabilities across the company’s global suite of
April 13, 2020 10:01
Masimo Announces Full Market Release of Masimo SafetyNet™, a Remote Patient Management Solution Designed to Aid COVID-19 Response Efforts
Masimo (NASDAQ: MASI) announced today the full market release of Masimo SafetyNet™, an innovative, economically scalable cloud-based patient management solution designed to help clinicians care for pa
April 09, 2020 17:29
European Commission Approves Takeda’s ALUNBRIG® (brigatinib) as a First-Line Treatment for ALK+ NSCLC
Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) today announced that the European Commission (EC) extended the current marketing authorization of ALUNBRIG (brigatinib) to include use as a mo
April 08, 2020 16:14
COVID-19: Boehringer Ingelheim steps up effort with Global Support Program
Boehringer Ingelheim has significantly stepped up its support to the fight against Covid-19. A Global Support Program has been set up to bring more financial relief, protective materials and medicine
April 08, 2020 13:54
St. Luke’s University Health Network One of the First in the World to Pilot Masimo SafetyNet™, a Remote Patient Management Solution, to Aid Hospitalized COVID-19 Patients
Masimo (NASDAQ: MASI) announced today that St. Luke’s University Health Network (SLUHN) is one of the first institutions worldwide to use Masimo SafetyNet™ to monitor in-hospital patients, as the netw
April 08, 2020 12:56
Global Plasma Leaders Collaborate to Accelerate Development of Potential COVID-19 Hyperimmune Therapy
Biotest, BPL, LFB, and Octapharma have joined an alliance formed by CSL Behring (ASX:CSL/USOTC:CSLLY) and Takeda Pharmaceutical Company Limited (TOKYO:4502/NYSE:TAK) to develop a potential plasma-deri
April 08, 2020 09:00
Morinaga Milk Obtains FDA GRAS Approval for Its Probiotic Bifidobacterium longum BB536 in Infant Formula
Morinaga Milk Industry Co., Ltd. (TOKYO:2264), a leading Japanese dairy product company, today announced its proprietary probiotic Morinaga Bifidobacterium longum BB536 has received FDA GRAS (Generall
April 07, 2020 16:18
LFB Announces FDA Approval of SEVENFACT®, a New Recombinant Coagulation Factor VIIa, for the Treatment of Adults and Adolescents with Hemophilia A or B with Inhibitors
LFB today announced that the US Food and Drug Administration (FDA) has approved the Biologics License Application (BLA) 2061 for SEVENFACT®, a new recombinant coagulation Factor VIIa [coagulation fact
April 03, 2020 13:00
MAK's Oracle Water System Represents Device for Preventing COVID-19
“As it is harmless, I readily clean my hands using ‘Oracle Water’ after returning home, instead of other hand-detergents,” said a citizen of Daegu who was receiving the antiseptic solution at a commun
April 03, 2020 11:59
Largest Statistically Significant Study by 6,200 Multi-Country Physicians on COVID-19 Uncovers Treatment Patterns and Puts Pandemic in Context
Widespread confusion, conflicting reports, inconsistent testing, and off-indication use of existing and experimental drugs has resulted in no single source of information from the frontlines. To creat
April 02, 2020 14:11
EUSA Pharma and Papa Giovanni XXIII Hospital, Italy, Provide Interim Analysis Data for Siltuximab-Treated COVID-19 Patients from the SISCO Study
EUSA Pharma, a global biopharmaceutical company focused on oncology and rare disease, today announced initial preliminary findings from the Papa Giovanni XXIII Hospital sponsored SISCO (Siltuximab In
April 01, 2020 15:29
Takeda Adopts Executive Compensation Recoupment Policy
Takeda Pharmaceutical Company Limited (TOKYO:4502/NYSE:TAK) (“Takeda”) today announced that its Board of Directors approved an executive compensation recoupment policy (“clawback policy”). The adoptio
April 01, 2020 13:04
Takeda Receives Positive CHMP Opinion for ADCETRIS® (brentuximab vedotin) in Combination with CHP (Cyclophosphamide, Doxorubicin and Prednisone) for Treatment of Adult Patients with Previously Untreated Systemic Anaplastic Large Cell Lymphoma
Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) granted a positive
March 31, 2020 13:57
Drug Candidates (SACT-COV19) for Coronavirus Disease 2019 (COVID-19) under Existing Smart-ACT™ Platform and Acticule Infectious Disease Platform
Aptorum Group Limited (Nasdaq: APM) (“Aptorum Group”), a biopharmaceutical company focused on the development of novel therapeutics for unmet needs including but not limited to infectious, orphan and
March 30, 2020 11:43
DeltaTrak Announces New Non-Contact Forehead Infrared Thermometer to Aid in Coronavirus Prevention
DeltaTrak®, a leading innovator of cold chain management and temperature monitoring solutions, announces the immediate availability of the new Model 15004 Non-Contact Forehead Infrared Thermometer tha
Oracle Water, produced with Oracle Water System which is a powerful epidemics prevention solution de
March 30, 2020 10:13
MAK's Oracle Water with Outstanding Cleansing and Sterilizing Power Demonstrates Effect of Preventing COVID-19
‘Oracle Water’, produced with Oracle Water System which is a powerful epidemics prevention solution developed by MAK, demonstrated the remarkable effect of preventing COVID-19. Oracle Water was beg
March 30, 2020 09:55
Siemens Energy Korea relocates the office building to Chungjeong-ro
Siemens Energy Korea (Siemens Energy Ltd·SEL) said on March 30 that it relocate the office building to the Poongsan Building in Chungjeong-ro, Seoul. With the relocation, they announced its launch as
March 27, 2020 13:50
ExThera’s Affinity Blood Filter Is Used to Treat COVID-19 Patients
Treatment of COVID-19 with ExThera’s Seraph®100 Microbind® Affinity Blood Filter (Seraph 100) has begun in hospitals in Germany and Italy. Seraph 100 treatments of COVID-19 are also expected to begin
March 26, 2020 14:13
Multi-Lingual Support From the Global MediXchange of Combating COVID-19 (GMCC) Programme to Further Enable Sharing Among Medical Personnel Worldwide
Over 440 medical institutions from 104 countries and regions have applied to learn and share experiences in battling COVID-19 through the International Medical Expert Communication Platform. The Handb
March 26, 2020 10:29
Tanner Pharma Group Announces LEUKINE EMERGENCY ACCESS PROGRAM (LEAP) to Provide Increased International Access to LEUKINE® (sargramostim)
Tanner Pharma Group today announced they are expanding their program by which the company provides access to LEUKINE® (sargramostim) in international markets. LEUKINE®, approved by the US FDA in 1991
25 per page50 per page75 per page100 per page